Cite
HARVARD Citation
Tuccinardi, D. et al. (2019). Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six‐month, randomized, placebo‐controlled, double‐blind clinical trial. Diabetes, obesity & metabolism. 21 (6), pp. 1487-1492. [Online].